Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Search results

Found 9997 matches for

Oxford-GSK collaboration in Biostatistics and Artificial Intelligence in Medicine

Combining machine-learning algorithms and infectious diseases epidemiology in zoonotic disease surveillance and pandemic response

An Agent Based Approach to Healthcare Modelling with Big Data and AI

The Pioneer Centre for Statistical and computational Methods for Advanced Research to Transform

Disease Modelling Group

The Disease Modelling Group aim is to create dynamic mathematical modelling solutions to inform and support key global and local health policy decisions - in relation to infectious diseases across the world, with the overall goal of improving human health.

Health Data Research UK – Oxford Region

Computational Rare Disease Genomics Group

Efficient large-scale pre-training for foundation wearable models

Vaccine equity and trachoma resurgence

Graph learning and complex network analysis of clinical symptoms related to severe schistosomiasis

Learning anatomy of the spine using Foundation Models (SpineFM)

SchistoTrack

A prospective multimorbidity cohort.

Wearables Group

PhD Vacancy - Harwell/BDI

Funded DPhil project: An investigation into the utility of smartphone-based citizen science projects for understanding brain health

Adverse risks of obesity

A socio-ethical investigation of stakeholders’ views of the use of photographs in biomedical research

Modelling adverse event processing in clinical trials

Objectively measuring physical activity and its health consequences

Using metabolomics to identify causal biomarkers in the development of diabetes